1. Home
  2. CRC vs CRSP Comparison

CRC vs CRSP Comparison

Compare CRC & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

N/A

Current Price

$53.96

Market Cap

4.8B

Sector

Energy

ML Signal

N/A

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$51.34

Market Cap

4.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRC
CRSP
Founded
2014
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.8B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
CRC
CRSP
Price
$53.96
$51.34
Analyst Decision
Strong Buy
Buy
Analyst Count
13
23
Target Price
$75.33
★ $85.63
AVG Volume (30 Days)
724.3K
★ 1.4M
Earning Date
11-02-2026
11-09-2026
Dividend Yield
★ 2.99%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
N/A
Revenue
★ $3,669,000,000.00
$289,590,000.00
Revenue This Year
$5.44
$1,052.09
Revenue Next Year
N/A
$280.75
P/E Ratio
★ N/A
N/A
Revenue Growth
14.73
★ 9169.85
52 Week Low
$43.25
$44.12
52 Week High
$71.98
$65.98

Technical Indicators

Market Signals
Indicator
CRC
CRSP
Relative Strength Index (RSI) 52.56 47.75
Support Level $50.16 $50.19
Resistance Level $55.12 $60.71
Average True Range (ATR) 1.66 2.15
MACD 0.12 -0.04
Stochastic Oscillator 77.40 58.72

Price Performance

Historical Comparison
CRC
CRSP

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: